Jeffrey M. Jonas, President & CEO at Sage Therapeutics, Inc. (SAGE), sold 84,661 shares at $176.44 ($14.8M) on 2019-05-28, disclosed to the SEC on 2019-05-29.
Open-market sale of $14.8M SAGE by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $173.62 | 25,510 | $4.4M | 29.9% |
| 2 | $174.48 | 28,293 | $4.9M | 33.4% |
| 3 | $175.72 | 16,651 | $2.9M | 19.8% |
| 4 | $176.44 | 11,662 | $2.1M | 13.9% |
| 5 | $177.62 | 2,545 | $452K | 3.1% |
| Total | $174.83 avg | 84,661 |
| $14.8M |
| 100% |
| Filing → |
| KRTX | SELL | 2023-07-05 | $6.0M | — | Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |